Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism STK17B inhibitors(serine/threonine kinase 17b inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Arthritis | Discovery | - | 19 May 2023 | |
| Autoimmune Diseases | Discovery | - | 19 May 2023 | |
| Digestive System Disorders | Discovery | - | 19 May 2023 | |
| Dystrophy, Macular | Discovery | - | 19 May 2023 | |
| Endocrinology and Metabolic Disease | Discovery | - | 19 May 2023 | |
| Myelodysplastic Syndromes | Discovery | - | 19 May 2023 | |
| Neoplasms | Discovery | - | 19 May 2023 | |
| Nervous System Diseases | Discovery | - | 19 May 2023 | |
| Other Diseases | Discovery | - | 19 May 2023 |





